Health Condition 1: null- patients with extensive disease or unsalvageable recurrence where the options of surgery, radiation and conventional chemotherapy are exhausted, unsuitable or are refused by the patient
Conditions
Interventions
Intervention1: Electrochemotherapy: The procedure would be performed under general anaesthesia or under local infiltration with 2% lignocaine-adrenaline and bupivacaine when feasible. Surface needle e
Sponsors
Tata memorial hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients of either gender aged > 18yrs 2 Head and neck cancer and breast patients with advanced skin involvement not suitable for conventional therapeutic treatments 3 Head and neck and breast cancer patients having recurrent disease where options of surgery, radiation and chemotherapy are exhausted and cannot be used 4 Patient refusing conventional modalities of treatment 5 Patients willing to consent for electrochemotherapy
Exclusion criteria
Exclusion criteria: 1 Patients with deranged renal functions 2 Patients with severe systemic disease 3 Patients with severe co-morbidity medically unfit to undergo procedure 4 Patients allergic to bleomycin/ cisplatin 5 Patients not willing to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the response rates to electrochemotherapy for head and neck and breast cancer patients in a palliative settingTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of lifeTimepoint: not applicable | — |
Countries
India
Contacts
Public ContactDr Devendra Arvind Chaukar
Tata memorial hospital
Outcome results
None listed